Table 1.
Characteristics of the SARS-CoV-2 patients.
| Parameters | Values |
|---|---|
| SARS-CoV-2 subjects—n | 64 |
| Age (years) | 57 (25–98) |
| Sex (female sex)—n (%) | 23 (36.0) |
| Time of hospitalization (days) | 7 (1–23) |
| Time of symptoms (days) | 16 (8–38) |
| Pneumonia—n (%) | 59 (92.2) |
| Deaths—n (%) | 6 (9.4) |
| Comorbidities—n (%) | |
| Hypertension | 15 (27.8) |
| Diabetes | 7 (11) |
| Treatment during hospitalization—n (%) | |
| Oxygen therapy | 64 (100) |
| Kaletra + Hydroxycloroquine + Azithromycin | 29 (45.4) |
| Remdesivir + Dexamethasone + Heparin | 33 (51.6) |
| Clinical data at admission | |
| Hemoglobin (g/dL) | 13.7 (8–19) |
| Platelets (cells/mm3) | 204 (104–459) |
| Lymphocytes (cells/mm3) | 1114 (140–3628) |
| Monocytes (cells/mm3) a | 450 (120–1170) |
| Neutrophils (cells/mm3) a | 3236 (831–9631) |
| Creatinine (mg/dL) b | 0.8 (0.4–1.4) |
| D-dimer (ng/mL) b | 460 (140–2500) |
| PCR (mg/L) b | 37.3 (0.3–376.5) |
Values are taken at baseline. Categorical variables are expressed as numbers and percentages (%). Percentages have been rounded per convention. Continuous variables are expressed as median and interquartile range (IQR). a,b Data only available from 54 and 58 patients, respectively. Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; PCR, C-reactive protein.